SCHEMBL6067916

SCHEMBL6067916

O=[N+]([O-])c1ccc(-c2cc(O)cc(O)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.59
PTGS2 P35354 1/20 0.59
ABL1 P00519 1/20 0.54
ABCB1 P08183 1/20 0.54
BCR P11274 1/20 0.54
MAPK1 P28482 3/20 0.50
POLB P06746 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
ALDH1A1 P00352 4/20 0.48
TSHR P16473 2/20 0.48
APP P05067 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP19A1 P11511 1/20 0.48
MAPT P10636 5/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29199081 0.85 CA1 (0.55) PTGS1PTGS2MAPK1POLBCA12
SCHEMBL1539361 0.85 CA1 (0.55) PTGS1PTGS2MAPK1POLBCA12
SCHEMBL9321465 0.84 CA1 (0.59) MAPK1POLBCA12CA1CA2
SCHEMBL28239060 0.83 CA1 (0.53) PTGS1PTGS2MAPK1POLBCA12
SCHEMBL28198 0.82 CA1 (0.67) MAPK1POLBCA12CA1CA2
SCHEMBL6423919 0.82 CA1 (0.67) MAPK1POLBCA12CA1CA2
SCHEMBL11025543 0.80 CYP19A1 (0.50) PTGS1PTGS2ABL1ABCB1BCR
Water SCHEMBL28670631 0.79 CA1 (0.64) MAPK1POLBCA12CA1CA2
SCHEMBL28132957 0.79 CYP19A1 (0.67) ABL1ABCB1BCRMAPK1ALDH1A1
SCHEMBL9807385 0.79 ALDH1A1 (0.53) PTGS2MAPK1POLBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125428-B2 1,3-Dihydroxybenzene derivatives and colorants containing said compounds WELLA AG (DE) 2006-10-24 US disclosed
EP-1392673-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2004-03-03 EP disclosed
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2004-01-29 US disclosed
WO-2002096901-A2 1,3-DIHYDROXYBENZENE DERIVATIVES AND COLORANTS CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-12-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040016063-A1 1,3-Dihydroxybenzene derivatives and colorants containing said compounds KRT18, DSP, COL1A1 PTGS1 869/4885PTGS2 1617/4885ABL1 2506/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.